Concepedia

S. van der Vegt

SV

Statistics

Publications

3

Citations

541

H-Index

3

Active since

1992

Affiliations

Universitair Ziekenhuis Leuven(Current)

S. van der Vegt is an author at Universitair Ziekenhuis Leuven specializing in medicine, pharmacology, and oncology.

Top concepts

MedicinePharmacologyOncologyPharmacotherapyRadiation OncologyCardiologyBreast CancerCancer TherapyCardiovascular DiseaseCardiovascular Pharmacology

Publications per year

1992–2011

3

Publications

3

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Richard J. Gralla, M. Lichinitser, S. van der Vegt et al. · Annals of Oncology · 2003 · 471 citations

Emetogenic Chemotherapy, Oncology, Chemotherapy-induced Nausea +5

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial

Daniel Rayson, Thomas Suter, Christian Jackisch et al. · Annals of Oncology · 2011 · 39 citations · Full text

Cardiovascular Disease, Medicine, Cardiovascular Pharmacology +7

Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer

Jan H. Schornagel, S. van der Vegt, Jaap Verweij et al. · Annals of Oncology · 1992 · 31 citations · Full text

Metastatic Breast Cancer, Oncology, Breast Oncology +7

1–3 of 3